Microalgae polysaccharides ameliorates obesity in association with modulation of lipid metabolism and gut microbiota in high-fat-diet fed C57BL/6 mice
Comparing Clinical Evidence: GLP-1 Receptor Agonists vs Antioxidant Therapy Randomized controlled trials of semaglutide, including SUSTAIN and STEP studies, consistently show significant weight loss, improved blood sugar control, and reduced cardiovascular risk markers
Conditions to review include immunodeficiencies (IgA deficiency, combined variable immunodeficiency, and graft- vs- host disease), autoimmune enteropathy, collagen vascular diseases and vasculitides, radiation enteritis, ischemia, mastocytosis, abetalipoproteinemia, and endocrinopathies (thyroid and adrenal)
In 2026, staying on top of these coding nuances isnt just about paperwork
1 L fluids NAD + and a unique blend of antioxidants, vitamin C, glutathione, magnesium